Molecular Mechanisms and Clinical Implications of Fibroblast Growth Factor Receptor 2 Signaling in Gastrointestinal Stromal Tumors

主旨 癌症研究 间质细胞 生物 受体酪氨酸激酶 酪氨酸激酶 酪氨酸激酶抑制剂 PDGFRA公司 点突变 伊马替尼 受体 生长因子受体 生物标志物 突变 成纤维细胞生长因子受体2 信号转导 癌症 抗药性 成纤维细胞生长因子受体1 甲磺酸伊马替尼 基因 成纤维细胞 间质瘤 生物信息学 成纤维细胞生长因子受体 基因突变 生长因子 医学 成纤维细胞生长因子 成纤维细胞生长因子受体4 遗传学 靶向治疗 微阵列
作者
Yanyun Hong,Xiaodong Wang,Chunhui Shou,Xiaosun Liu
出处
期刊:Current Issues in Molecular Biology [Caister Academic Press]
卷期号:47 (10): 822-822 被引量:1
标识
DOI:10.3390/cimb47100822
摘要

Introduction: Gastrointestinal stromal tumors (GISTs) are primarily driven by mutations in KIT (KIT proto-oncogene receptor tyrosine kinase) or PDGFRA (platelet-derived growth factor receptor alpha), but resistance to tyrosine kinase inhibitors (TKIs) such as imatinib remains a major clinical challenge. Alterations in fibroblast growth factor receptor 2 (FGFR2), although rare, are emerging as important contributors to tumor progression and drug resistance. This review evaluates the molecular mechanisms, expression profiles, detection methods, and therapeutic implications of FGFR2 in GIST. Methods: We searched PubMed, Web of Science, Google Scholar, and ClinicalTrials.gov for studies published between January 2010 and June 2025, using combinations of keywords related to FGFR2, gastrointestinal stromal tumor, resistance mechanisms, gene fusion, amplification, polymorphisms, and targeted therapy. Eligible studies were critically assessed to distinguish GIST-specific data from evidence extrapolated from other cancers. Results:FGFR2 is expressed in multiple normal tissues and at variable levels in mesenchymal-derived tumors, including GIST. Its alterations occur in approximately 1–2% of GIST cases, most commonly as gene fusions (e.g., FGFR2::TACC2, <1%) or amplifications (1–2%); point mutations and clinically significant polymorphisms are extremely rare. These alterations activate the MAPK/ERK and PI3K/AKT pathways, contribute to bypass signaling, and enhance DNA damage repair, thereby promoting TKI resistance. Beyond mutations, mechanisms such as amplification, ligand overexpression, and microenvironmental interactions also play roles. FGFR2 alterations appear mutually exclusive with KIT/PDGFRA mutations but occasional co-occurrence has been reported. Current clinical evidence is largely limited to small cohorts, basket trials, or case reports. Conclusions:FGFR2 is an emerging oncogenic driver and biomarker of resistance in a rare subset of GISTs. Although direct evidence remains limited, particularly regarding DNA repair and polymorphisms, FGFR2-targeted therapies (e.g., erdafitinib, pemigatinib) show potential, especially in combination with TKIs or DNA-damaging agents. Future research should prioritize GIST-specific clinical trials, the development of FGFR2-driven models, and standardized molecular diagnostics to validate FGFR2 as a therapeutic target.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
www发布了新的文献求助10
2秒前
3秒前
健忘的麦片完成签到,获得积分10
3秒前
wllshr完成签到 ,获得积分10
3秒前
3秒前
4秒前
堪曼凝发布了新的文献求助10
4秒前
千空发布了新的文献求助10
4秒前
顺利怜菡完成签到,获得积分20
4秒前
寂寞的小鱼的应助被落雪采纳,获得10
5秒前
大个的应助被corleeang采纳,获得10
5秒前
NCWUniu完成签到,获得积分10
5秒前
小左发布了新的文献求助10
6秒前
zz发布了新的文献求助10
6秒前
6秒前
伶俐耳机完成签到 ,获得积分10
7秒前
受伤海秋完成签到,获得积分10
7秒前
8秒前
郭郭发布了新的文献求助10
8秒前
水煮电吹风的应助被机智雅山采纳,获得10
9秒前
ciao完成签到 ,获得积分10
10秒前
10秒前
lin01发布了新的文献求助10
10秒前
11秒前
完美世界的应助被科研通管家采纳,获得10
11秒前
852的应助被n11采纳,获得10
11秒前
Owen的应助被科研通管家采纳,获得10
11秒前
11秒前
无花果的应助被小卢采纳,获得10
11秒前
李爱国的应助被科研通管家采纳,获得10
11秒前
拯救小岛发布了新的文献求助10
11秒前
天天快乐的应助被科研通管家采纳,获得10
12秒前
SciGPT的应助被corleeang采纳,获得10
12秒前
Akim的应助被科研通管家采纳,获得10
12秒前
12秒前
星辰大海的应助被科研通管家采纳,获得10
12秒前
我是老大的应助被救救我采纳,获得10
12秒前
研友_VZG7GZ的应助被科研通管家采纳,获得10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183241
求助须知:如何正确求助?哪些是违规求助? 9572493
关于积分的说明 21826218
捐赠科研通 7780115
什么是DOI,文献DOI怎么找? 3433982
关于科研通互助平台的介绍 2558103
邀请新用户注册赠送积分活动 2480192